Markets: 2026-09-28 Close

A sourced recap of the previous completed U.S. trading session. Closing moves are not real-time quotes.

What moved

- **S&P 500 (SPX)**: -0.77%, closed at 7,683.69 - **Nasdaq Composite (COMP)**: -0.92%, closed at 26,820.38 - **Dow Jones Industrial Average (DJIA)**: -0.67%, closed at 51,481.51 - **Russell 2000 (RUT)**: -0.69%, closed at 2,817.91

Sector leaders and laggards

- Leaders: Consumer staples +0.40%; Health care +0.29%; Energy +0.22% - Laggards: Communication services -1.67%; Consumer discretionary -1.58%; Financials -1.14%

Evidence behind the moves

Kodiak Sciences Inc. (KOD) +177.96%

Kodiak reported that both investigational treatments met the primary endpoints in its Phase 3 DAYBREAK wet-AMD trial. The trial readout more than doubled the shares and also moved competing retinal-drug stocks.

Sources: September 28 closing price, change and volume · Market capitalization · Company-confirmed catalyst

MongoDB, Inc. (MDB) -18.46%

MongoDB announced that CEO Chirantan 'CJ' Desai had stepped down effective immediately; Meta separately announced he would lead its new enterprise platform. An abrupt leadership change coincided with an unusually large selloff in a major database-software company.

Sources: September 28 closing price, change and volume · Market capitalization · Company-confirmed catalyst

The Boeing Company (BA) -6.91%

The FAA said it would delay certification of Boeing's 737 MAX 10 while a newly disclosed software issue is resolved. The delay affects certification of the largest 737 MAX variant and sent a heavily traded industrial stock sharply lower.

Sources: September 28 closing price, change and volume · Market capitalization · Corroborating catalyst and closing-direction reporting

NVIDIA Corporation (NVDA) +1.68%

NVIDIA announced a $150 billion increase to its share-repurchase authorization, bringing its stated remaining authorization to $235 billion. The market's most heavily traded stock rose despite declines in all four broad indexes shown above.

Sources: September 28 closing price, change and volume · Market capitalization · Company-confirmed catalyst

Meta Platforms, Inc. (META) -4.79%

Meta announced an enterprise AI platform and named former MongoDB CEO Chirantan Desai to lead it. The announcement is confirmed, but it does not by itself establish why Meta shares fell. The large-cap decline occurred on the same day as a consequential enterprise-AI expansion and the leadership move that affected MongoDB.

Sources: September 28 closing price, change and volume · Market capitalization · Confirmed announcement; not a confirmed cause of the decline

Ocular Therapeutix, Inc. (OCUL) -20.67%

Shares fell as Kodiak's positive wet-AMD trial results sharpened the perceived competition for Ocular's investigational AXPAXLI treatment. A competitor's clinical result produced a substantial move in a separate, liquid drug developer.

Sources: September 28 closing price, change and volume · Market capitalization · Corroborating catalyst reporting

Bloom Energy Corporation (BE) -8.95%

Investors weighed previously reported potential delays at Oracle's Project Jupiter data-center development, where Bloom fuel cells were planned as a power source. The project's news predates this session, so its precise contribution to Monday's move is uncertain. A sharp decline in a liquid data-center power supplier highlighted sensitivity to AI-buildout execution risk.

Sources: September 28 closing price, change and volume · Market capitalization · Earlier Project Jupiter reporting; session causation unconfirmed

Regeneron Pharmaceuticals, Inc. (REGN) -4.54%

Kodiak reported successful wet-AMD trial results against aflibercept, the active ingredient in Regeneron's Eylea. The result raised potential competitive concerns; it was not a finding about Regeneron's own products. The same clinical readout that drove Kodiak higher also put a much larger incumbent under pressure.

Sources: September 28 closing price, change and volume · Market capitalization and Eylea product context · Competitor's primary announcement

What remains uncertain

The cited announcements establish events and reported explanations, not the fraction of each price move caused by them. Unconfirmed catalysts remain hypotheses. Closing figures describe this session only.

What to watch next

Check subsequent company filings and results against the claims above, and whether the next sessions sustain or reverse these moves. A follow-up headline alone does not confirm the original explanation.

Stock spotlight

Today’s detailed follow-up focuses on **Kodiak Sciences Inc. (KOD)**, the strongest verified editorial candidate from this slate.

_MacroShed Markets is informational analysis, not investment advice._